Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development (Q35789894)
scientific article published on June 2004
Language:
Current Data About Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development
(P31) (Q13442814)
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

(Q7318358)
(P248)

(P304) 3885-3896
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

(P407) (Q1860)

(P433) 11
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

(P478) 10
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

(P577) Tuesday, June 1, 2004
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

(P921) (Q864574)

(P1433) (Q332253)
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

(P1476) "Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development" (language: en)
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

(P2093) John W Park
(P1545) 1
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

Robert S Kerbel
(P1545) 2
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

Gary J Kelloff
(P1545) 3
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

J Carl Barrett
(P1545) 4
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

Bruce A Chabner
(P1545) 5
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

David R Parkinson
(P1545) 6
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

Jonathan Peck
(P1545) 7
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

Raymond W Ruddon
(P1545) 8
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

Caroline C Sigman
(P1545) 9
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

Dennis J Slamon
(P1545) 10
(P248)
(P698) 15173098
(P813) Thursday, August 10, 2017

other details
description scientific article published on June 2004

External Links
(P356) 10.1158/1078-0432.CCR-03-0785
(P698) 15173098